SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 124 filers reported holding SYNDAX PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $20,776 | +739.4% | 1,012 | +873.1% | 0.00% | – |
| Q1 2024 | $2,475 | +227.4% | 104 | +197.1% | 0.00% | – |
| Q4 2023 | $756 | -18.6% | 35 | -45.3% | 0.00% | – |
| Q3 2023 | $929 | -96.9% | 64 | -95.5% | 0.00% | – |
| Q2 2023 | $29,972 | +166411.1% | 1,432 | +68.1% | 0.00% | – |
| Q1 2023 | $18 | +1700.0% | 852 | +1928.6% | 0.00% | – |
| Q4 2022 | $1 | -99.9% | 42 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | -97.4% | 42 | -98.1% | 0.00% | – |
| Q1 2022 | $38,000 | +8.6% | 2,160 | 0.0% | 0.00% | – |
| Q4 2021 | $35,000 | -23.9% | 2,160 | -10.0% | 0.00% | – |
| Q3 2021 | $46,000 | +12.2% | 2,400 | 0.0% | 0.00% | – |
| Q2 2021 | $41,000 | +272.7% | 2,400 | +380.0% | 0.00% | – |
| Q1 2021 | $11,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2020 | $11,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |